Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Cardiac resynchronization therapy devices (CRT)
Implantable cardioverter defibrillators (ICD)
Leads, implantable devices
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
Cardiovascular Systems Inc.
1225 Old Highway 8 NW
St. Paul, MN 55112
Peripheral Artery Disease (PAD)
May 12, 2015
Long-Term Economic Data Shows Savings With Atherectomy in ORBIT II Trial
Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s Diamondback 360 ...
April 24, 2015
Cardiovascular Systems Receives FDA Clearance for New Peripheral Diamondback Device
Cardiovascular Systems Inc. announced that it has received U.S. Food and Drug Administration (FDA) clearance for the 4...
November 06, 2014
Cardiovascular Systems Receives CE Mark for Atherectomy System
Cardiovascular Systems Inc. received the CE Mark for its Stealth 360º Orbital Atherectomy System (OAS). Stealth 360º is...
October 30, 2014
Cardiovascular Systems Enrolls First Seven Patients in Japan for Coast Study
Cardiovascular Systems Inc. announced that the first seven patients in Japan have been enrolled in its Coronary Orbital...
August 19, 2014
Class 1 Recall Initiated for Diamondback 360 Peripheral Orbital Atherectomy System
Cardiovascular Systems is recalling certain lots of the Diamondback 360 Peripheral Orbital Atherectomy System, because...
June 12, 2014
Cardiovascular Systems Enrolls First Patient in Study of New Atherectomy System
Cardiovascular Systems Inc. (CSI) announced that the first patient has been enrolled in its Coronary Orbital...
June 09, 2014
ORBIT II Study One-Year Results Demonstrate Orbital Atherectomy Improves Outcomes in High-Risk Patients
June 9, 2014 — After one year, patients treated with orbital atherectomy, a procedure to sand away calcium in the...
April 21, 2014
Robert Wood Johnson Treats Calcified Lesions Transradially
Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited...
March 11, 2014
FDA Clears Cardiovascular Systems’ 60 cm Diamondback Devices
The U.S. Food and Drug Administration (FDA) cleared Cardiovascular Systems Inc.’s Diamondback 360 60 cm Peripheral...
December 10, 2013
Mount Sinai Hospital First in World to Offer Patients New FDA-Approved Device for Severely Calcified Arteries
Interventional cardiologists at Mount Sinai Hospital are the first in the world to use a newly U.S. Food and Drug...
Scranton Gillette Communications
. All Rights Reserved.
Terms and Conditions